Is CPHRF or RYLD a better dividend investment in 2026?

CPHRF currently yields 15.38% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: CPHRF offers higher current income.

What is the dividend yield difference between CPHRF and RYLD?

CPHRF has a forward dividend yield of 15.38% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 2.99 percentage points.

Home › Compare › CPHRF vs RYLD

CPHRF vs RYLD: Dividend Comparison 2026

CPHRF yields 15.38% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CPHRF wins by $9.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CPHRF

● Live price

15.38%

Share price

$13.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$54.8K

Annual income

$3,973.98

Full CPHRF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — CPHRF vs RYLD

📍 CPHRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CPHRF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CPHRF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CPHRF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CPHRF

Annual income on $10K today (after 15% tax)

$1,307.69/yr

After 10yr DRIP, annual income (after tax)

$3,377.88/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, CPHRF beats the other by $1,097.35/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CPHRF + RYLD for your $10,000?

CPHRF: 50%RYLD: 50%

100% RYLD50/50100% CPHRF

Portfolio after 10yr

$50.0K

Annual income

$3,328.48/yr

Blended yield

6.65%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CPHRF right now

CPHRF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

8.2

Piotroski

8/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CPHRF buys

RYLD buys

No recent congressional trades found for CPHRF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCPHRFRYLD

Forward yield	15.38% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$54.8K ✓	$45.3K
Annual income after 10y	$3,973.98 ✓	$2,682.98
Total dividends collected	$26.9K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CPHRF vs RYLD ($10,000, DRIP)

Year	CPHRF Portfolio	CPHRF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,238	$1,538.46	$11,939	$1,239.34	+$299.00 → CPHRF
2	$14,855	$1,759.66	$14,158	$1,382.89	+$697.00 → CPHRF
3	$17,891	$1,996.12	$16,682	$1,532.59	+$1.2K → CPHRF
4	$21,390	$2,246.80	$19,537	$1,687.64	+$1.9K → CPHRF
5	$25,398	$2,510.50	$22,752	$1,847.20	+$2.6K → CPHRF
6	$29,961	$2,785.88	$26,355	$2,010.43	+$3.6K → CPHRF
7	$35,130	$3,071.47	$30,376	$2,176.45	+$4.8K → CPHRF
8	$40,955	$3,365.74	$34,847	$2,344.43	+$6.1K → CPHRF
9	$47,489	$3,667.11	$39,800	$2,513.54	+$7.7K → CPHRF
10	$54,787	$3,973.98	$45,269	$2,682.98	+$9.5K → CPHRF

CPHRF vs RYLD: Complete Analysis 2026

CPHRF — Stock

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.

Full CPHRF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this CPHRF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CPHRF vs SCHD CPHRF vs JEPI CPHRF vs O CPHRF vs KO CPHRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.